Efficient and Safe Application of a FOLFIRI/Bevacizumab Combination to a Patient with Locally Advanced Rectal Cancer and Severe Chronic Renal Failure

Publisher： Karger

E-ISSN： 2296-5262|30|1-2|65-65

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.30, Iss.1-2, 2007-01, pp. : 65-65

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Feasibility of Using Cetuximab and Bevacizumab in a Patient with Colorectal Cancer and Terminal Renal Failure

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 209-210

Karger

Access to resources Recommend Favorite

Radiotherapy and locally advanced rectal cancer

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 12, 2015-11 ,pp. : 1443-1445

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer

By  

Oncology, Vol. 77, Iss. 2, 2009-07 ,pp. : 113-119

Karger

Access to resources Recommend Favorite

Effectiveness of Trastuzumab (HerceptinTM) in a Patient with Locally Recurrent Breast Cancer after Cardiac Failure Caused by Severe Cytotoxic Pretreatment

By  

Oncology, Vol. 61, Iss. 4, 2001-11 ,pp. : 271-274

Karger

Access to resources Recommend Favorite

Safe Use of Oxaliplatin in a Patient with Metastatic Breast Cancer and Combined Renal and Hepatic Failure*

By  

Oncology Research and Treatment, Vol. 29, Iss. 6, 2006-05 ,pp. : 273-275

Karger

Access to resources Recommend Favorite